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Objectives: Due to globalised migratory processes, female genital mutilation/cutting (FGM/C) 
has spread to other countries, namely in Europe, where, despite a few exceptions, it remains a 
concealed problem. This study estimates the prevalence of FGM/C in Portugal, being the first 
national extensive one on this issue.  
Study design: Prevalence estimation. 
Methods: Using the extrapolation of country of origin prevalence data method and the 2011 
Census data, we estimated: FGM/C prevalence in Portugal for women in reproductive age and 
for all women aged 15 or older; and the number of girls (aged 0 to 14) living in Portugal who 
underwent or will probably undergo FGM/C.  
Results: We estimate that a total of 6.576 women living in Portugal aged 15 or older have 
undergone FGM/C and are unevenly distributed across the national territory. Also, we 
estimate that 1.830 girls living in Portugal have already or will probably undergo FGM/C until 
the age of 15. 
Conclusions: We estimated that more than 6 thousand women are currently living in Portugal 
with the consequences of genital cutting and that there are many girls who are still at risk. 
Both these groups need different kinds of intervention. Knowing the dimension of the problem 
and its geographic configuration will enable a more informed and targeted definition of health 
public policies toward the protection of its victims and at-risk prevention.  
 
 




Female genital mutilation (FGM) or female genital cutting (FGC) is widely recognized as a 
serious violation of human rights of women of all ages1. It constitutes a severe social gender-
based problem, rooted in an imbalance of power between men and women, and it reflects one 
of the many forms of violence against women, representing society’s control over women and 
perpetuating asymmetric normative gender roles harming women in multiple ways1, 2. FGM/C, 
a traditional practice embedded in the cultural framework, is, for the practicing communities, 
considered a rite of passage to adulthood necessary to raise a girl properly and to prepare her 
for marriage1, 3, 4. It is associated with the control of women’s bodies and sexuality by 
“guaranteeing” their virtue, fidelity, virginity, an enhancement of men’s pleasure, and family 
honour4-9. 
FGM/C has grievous consequences to women’s and girls’ sexuality (e.g., pain during 
intercourse, less sexual satisfaction), physical (e.g., recurrent urinary tract infections, childbirth 
complications) and psychological (e.g., anxiety, post-traumatic stress disorder) health, 
education, and empowerment4, 10-13. 
The World Health Organization defines FGM/C as “all procedures involving partial or total 
removal of the external female genitalia or other injury to the female genital organs for non-
medical reasons”1. The same organization classified the diverse practices into four types of 
FGM/C: Type I (clitoridectomy) – partial or total removal of the clitoris and/or the prepuce; 
Type II (excision) – partial or total removal of the clitoris and the labia minora, with or without 
excision of the labia majora; Type III (infibulation) – narrowing of the vaginal orifice with 
creation of a covering seal by cutting and appositioning the labia minora and/or the labia 
majora, with or without excision of the clitoris; and Type IV – all other harmful procedures to 
the female genitalia for non-medical purposes, such as pricking, piercing, incising, scraping, 
and cauterizing. 
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FGM/C is documented in 29 countries in Africa and Middle East although there are reports of 
FGM/C in many others, such as Mozambique, Malaysia, Israel, and Colombia14-17. A recent 
study has documented type IV FGM/C in the Tete province, Mozambique, where it is common 
among young girls to elongate the labia minora (procedure locally designated as puxa-puxa, 
kukhuna or kupfuna). In this region, it is also common for girls and women to insert products 
or medicines in the vagina “in order to close, tighten or reduce the vaginal canal”14.  
The prevalence of FGM/C varies greatly among the different countries and overall it is 
estimated that 100 to 140 million girls and women have already undergone FGM/C1 and that, 
globally, 90% of FGM/C include types I, II and IV, with type III making up for the remaining 
10%18. 
Our use of the FGM/C terminology is in line with the current research and debate among 
academics and international development and human rights agencies. The term “mutilation” 
was first used by the Inter-African Committee on Traditional Practices Affecting the Health of 
Women and Children in order to emphasize the seriousness of this practice and to distinguish 
it from circumcision, and has been adopted by the majority of agencies and institutions 
working in the field. However, the term “mutilation” was also found to be judgmental and its 
use to be potentially disrespectful when working with practicing communities. So, a hybrid 
term – FGM/C (female genital mutilation/cutting) – is used in order to encompass all those 
meanings and sensibilities1, 19. 
Specifically, this paper is intended to communicate a research project’s results regarding the 
estimation of the prevalence of FGM/C in Portugal, and of the number of girls at risk of FGM/C 
currently living in Portugal. 
Presently, there are few national studies in the European Union (EU) countries where the 
prevalence of FGM/C is estimated and Portugal is the eighth country to conduct such a study 
(among the 28 member states). This study thus contributes to data collection and discussion 
on this matter – a step which is “fundamental to targeted and evidence-based policy making 
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and measures”13 and to shed light on a concealed issue in terms of public action and debate, 
and its numbers and geographical dispersion. 
In Portugal, several studies on FGM/C have already been conducted. However, these solely 
mobilized a qualitative perspective, based on case studies or specific communities6-8, from the 
medical and health care standpoint4, 10, 20, or on the theoretical discussion regarding the 
associated social processes and legal issues21, 22. The aims of these analyses were mainly to 
uncover and to understand a reality still hidden in Portugal.  
Now, drawing from a quantitative perspective, this study adds the estimation of the number of 
women, currently living in Portugal, who have undergone FGM/C and of the number of girls 







We conducted a thorough review of the methodological options chosen by national studies on 
the prevalence of FGM/C in the European Union with the aim of building a comparable 
knowledge set. Accordingly, we explored the strengths and limitations of prevalence studies 
from Italy23; Hungary24; Ireland25; Germany26; The Netherlands27; Belgium28; and England and 
Wales29. 
We found that there was no common methodology and that we would be hard pressed to 
provide an estimate that could be directly comparable to existing national studies. Therefore, 
we chose to follow the most recent research methodologies, which have already benefitted 
from the latest debates on the field. Although all these studies used the extrapolation of 
country of origin prevalence data method, there were major differences regarding the 
counting of the populations mainly due to different conceptual approaches and data 
availability.  
The extrapolation of country of origin prevalence data method, which was the one used to 
estimate FGM/C prevalence in Portugal, consists of multiplying the prevalence of the country 
of origin by the number of women born in each of those countries residing in Portugal. In 
short, we are applying the proportion of FGM/C of the country of origin to the host country. In 
order to compute more accurate estimates, we use age-specific prevalence to capture 
previous reported differences in FGM/C prevalence among different age groups.  
In a strict sense, prevalence estimates regard only women in reproductive ages (15 to 49 years 
old). However, it was our aim to estimate the actual number of women currently living in 
Portugal with FGM/C. In order to do so, we also estimated its prevalence among women aged 
50 or more. Since there are no prevalence estimates for this age group, we used the closest 
age specific prevalence (45-49 years). Finally, in order to estimate the number of girls, 0 to 14 
years old, who have already undergone or will probably undergo FGM/C, we followed a similar 
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approach, in line with the most recent national EU studies (e.g., in England and Wales29). Using 
the 2011 Census data, we considered the number of girls aged less than 15 years, living in 
Portugal, who were born in countries where FGM/C is documented and the girls who were 
born in Portugal to mothers born in those same 29 countries. Although the father’s family 
may, in some ethnic groups, have great influence on the decision of cutting the child, there is 
no sufficient and reliable data that would enable the inclusion of these specificities in the 
estimations. Thus, we used the same methodological approach as in the most recent 
international studies27-29, which is to consider solely the mother’s country of birth. 
As there are no accurate prevalence estimates for this age group (0-14), we used the specific 




In order to employ the extrapolation of country of origin prevalence data method, we resorted 
to two different data sources: 1) the FGM/C prevalence in the country of origin, by age group; 
and 2) the number of women living in Portugal by country of birth and age. 
For the first data set, we used UNICEF’s data compiled from different surveys, namely DHS 
(Demographic and Health Surveys), MICS (Multiple Indicator Cluster Surveys), RHS 
(Reproductive Health Surveys) and SHHS (Sudan Household Health Survey). FGM/C is 
documented in 29 African and Middle Eastern countries with available prevalence estimates by 
age group. These 29 countries can be clustered in 5 groups: 1) high prevalence countries 
(above 80%), which include Somalia, Guinea, Djibouti, Egypt, Eritrea, Mali, Sierra Leone, and 
Sudan; 2) moderately high prevalence countries (51 to 80%) including Gambia, Burkina Faso, 
Ethiopia, Mauritania, and Liberia; 3) moderately low prevalence countries (26 to 50%) 
comprising Guinea-Bissau, Chad, Côte d’Ivoire, Kenya, Nigeria, and Senegal; 4) low prevalence 
countries (10 to 25%), which include Central African Republic, Yemen, United Republic of 
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Tanzania, and Benin; and, finally, 5) very low prevalence countries (below 10%) including Iraq, 
Ghana, Togo, Niger, Cameroon, and Uganda. 
Regarding data on the number of women and girls living in Portugal born in FGM/C practicing 
countries or born to mothers born in those countries, we used the latest Portuguese Census 
data (2011). Other sources, such as the national immigration office and the employment 
survey, were considered but found inadequate due to different constraints, namely the 
inexistence of information on the age group or other data for all the ages considered, a critical 
element for accurate prevalence estimations. 
To estimate the prevalence of FGM/C in Portugal (women aged 15 to 49; plus women over 49 
years), we compiled data on the resident population disaggregated by sex, age group, country 
of birth, and place of residence (region and municipality). We used the country of birth 
criterion and not nationality because a large parcel of these women may already have 
Portuguese citizenship (this is particularly common for women from Guinea Bissau, a former 






Working through the 2011 Census data, we found a total number of 10.617 women born in 
FGM/C practicing countries living in Portugal, aged 15 to 49 years. When adding the female 
population over 49 years, we reach a total of 13.335 women. 
Analysing the same data disaggregated by country of birth, we found that 89% of these 
women (in reproductive ages) come from Guinea-Bissau (9.452 women). Guinea-Bissau is, by 
far, the larger migrant community in Portugal among these 29 practicing countries, given the 
former colonial liaison and the current language proximity to Portugal. Other countries 
represent a considerably smaller percentage: we found 395 women from Senegal (3,7%); 161 
from Guinea (1,5%); and 136 from Nigeria (1,3%). This distribution, including the remaining 
practicing countries, is presented below (table 1).  
 
(Insert table 1) 
 
Extrapolating the age group specific prevalence of each country of birth to the number of 
women, currently living in Portugal, born in the documented practicing countries, we estimate 
that 5.246 women living in the Portuguese territory, aged between 15 and 49 years, have been 
subjected to FGM/C (table 2).  
If one also considers the female migrant population aged 50 or older, the women born in those 
29 countries and that are 15 or older represent a total of 13.335 (10.617 women aged 
between 15-49 years old, plus 2.718 women that are 50 or older). Extrapolating the prevalence 
of the 45-49 age group to the 2.718 women aged 50 or older, we estimate that, among these, 
1.330 women have probably been subjected to FGM/C. 
Therefore, adding up these figures, we estimate a total of 6.576 women, aged 15 or older, that 
have undergone FGM/C, currently living in Portugal (table 2). 
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(Insert table 2) 
 
We did not find, however, a uniform distribution of these women over the Portuguese 
territory: they are concentrated mainly in the Lisbon district (more than two thirds), while 14% 
live in Setúbal, an industrial region south of Lisbon (figure 1). Even within the Lisbon district, 
these communities tend to concentrate on five of its 16 municipalities: one-third in Sintra, 14% 
in Loures, 12% in Odivelas, 12% in Amadora, and 11% in the Lisbon municipality proper. 
Together, they congregate 84% of Lisbon districts’ prevalence. This observation is crucial for 
the definition of more targeted local policies and priorities regarding prevention and women’s 
health care.  
 
(Insert figure 1) 
 
Regarding the number of girls who have undergone or will probably undergo FGM/C, we 
resorted to the same data source in order to reach comparable and coherent results. 
According to the 2011 Census, there were a total of 3.832 girls living in Portugal who were 
either born in FGM/C practicing countries (1.273) or born to mothers originating from those 
countries (2.559).  
Although the effect of migrating to a foreign country should contribute to the decrease of this 
practice (as we will discuss below), we were not able to quantitatively include this effect in our 
estimation. There is no standard methodology to quantify the qualitative information that we 
can compile on this matter13. Among the national prevalence studies currently available in the 
EU, only the Italian tried to adjust their prevalence estimates by modifying the average FGM/C 
practicing countries’ prevalence used in the extrapolation method. However, since no 
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methodological description of the procedure is provides, we are not able to access its validity 
or applicability to other contexts23. 
Using the extrapolation of country of origin prevalence data method, and using the specific 15-
19 years old age group prevalence, we estimated that 1.830 girls living in Portugal have 
already or will probably undergo FGM/C until the age of 15 (table 3).  
 
(Insert table 3) 
 
Altogether, these data show that the prevalence of FGM/C in Portugal is 49%, meaning that we 
estimated that 5.246 of the 10.617 women in reproductive ages, from FGM/C practicing 
countries, living in Portugal, have been subjected to this practice. Overall, and also considering 
women aged 50 or older, this figure rises to 6.576 women. Regarding the girls who have 
already undergone or will probably undergo FGM/C, we estimate that there are 1.830 girls 
living in Portugal, born in FGM/C practicing countries or born to mothers from those countries, 
in this circumstance.  
These women, who have been subjected to FGM/C, will probably need specific medical 
attention. Since different studies have identified the need for specialized medical knowledge 
on this matter4, 20, 30, in line with other European countries31, knowing how many cases and 
where they are located could make the training of health care professionals become more 
effective. 
Although this may not represent a quantitatively major issue in Portugal (compared with the 
numbers concerning violence against women, which tell us that one in three women was a 
victim of physical, psychological, and/or sexual violence32), it is still a matter of great concern, 
as it symbolizes a severe form of gender-based violence that perpetuates power asymmetries 




This study, which was the first national extensive one on this matter, aimed to estimate the 
prevalence of FGM/C in Portugal. We were able to estimate that there are 6.576 women living 
in Portugal who were subjected to FGM/C (5.246 aged 15 to 49; and 1.330 aged 50 or older). 
We estimate that 1.830 girls living in Portugal have already or will probably undergo FGM/C 
until the age of 15. 
The currently available national prevalence studies in the EU reveal prevalences ranging from 
27 to 48%23-28. However, due to different methodological and conceptual approaches, these 
data are not comparable to ours, except for the most recent study from England and Wales29. 
Portuguese prevalence (49%) is in line with the one found in these two countries (48%), yet 
two very different realities emerge in absolute terms: while, in Portugal, these 49% represent 
5.246 women, in England and Wales 48% represent 137.000 women. 
In order to overcome these comparison limitations, a standard cross-country methodology is 
being developed, under a DAHNE Funding Program, by the University of Ghent in collaboration 
with the Institut National d’Etudes Démographiques (France), and the Department of 
Sociology of the Università degli Studi di Milano-Bicocca (Italy). Results are expected by the 
end of 2016. 
As previously suggested33, FGM/C prevalence tends to be reduced outside the communities of 
origin, due to a higher access to information and education resources, lower peer pressure, 
and the knowledge of a penalizing law in the host countries (in Portugal, FGM/C has recently 
been defined as an autonomous criminal offense, as per Law nº 83/2015, August 5th, Article 
144º A). However, the current study could not address this issue in a quantitative manner due 
to the time constraints that limited our methodological options. Hence, our prevalence 
estimates do not reflect the putative impact of migration even though this issue was 
addressed on the qualitative dimension of the broader research34 through in-depth interviews 
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(which took place in 2014 and 2015). The interviewees have shown some ambivalence 
regarding this specific matter. On the one hand, many of them believe that leaving their 
country and their community will relieve the social pressure to continue this tradition. This is 
due to integration and acculturation processes, as well as access to education, an important 
factor to raise critical reflexivity, and to symbolically deconstruct this practice. On the other 
hand, some of them state that this practice may represent one of the means of preserving a 
cultural connection to their birth communities. 
Therefore, in order to clarify immigration impact on FGM/C prevalence and to have more 
accurate estimates, upcoming studies should include this important dimension with a solid 
methodological foundation, namely by resorting to methodologies oriented for hard to reach 
populations, such as time-location sampling or response-driven sampling35, 36.  
The current study did not include numbers on refugees or asylum seekers since the 
responsible institution for this data was not able to provide disaggregated data. In any case, 
we analysed the United Nations’ Refugee Agency’s reports and the presented figures do not 
show Portugal as one of the major host countries for these populations37 (Portugal is not even 
referred to in the UNHCR update report of 201438; in 2014, 42 women from FGM/C practicing 
countries requested asylum39).Hence, the lack of this information should not have a major 
impact on the global figures presented in this study. 
Despite the above mentioned shortcomings, we were able to access highly disaggregated data 
– prevalence by age group, by country of birth, by district, and by municipality – which is very 
useful in identifying lifecycle specific needs for medical care and social services, and in 
providing regional and local institutions (NGOs, health care services, schools) with more 
specific information on the extent of the phenomenon in their territories. Precisely because 
this practice has major consequences on its victims’ health throughout their life, it is crucial 
that the access to, and the support from, health services are easily facilitated, this not being 
only a matter of human rights but also one of public health40.  
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This study has shown the magnitude and the geographic distribution of FGM/C in Portugal, a 
crucial set of information for a targeted definition of health public policies, as depicted in the 
3rd Programme of Action for the Prevention and Elimination of Female Genital Mutilation, in 
the framework of the 5th National Plan to Prevent and Combat Domestic and Gender-based 
Violence. Unveiling this reality constitutes an important step towards increasing awareness. 
This will ultimately contribute to the eradication of FGM/C, one of the many faces of gender-
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Figure 1. Distribution of women (15 years or older) who have undergone FGM/C, living in 
Portugal, per district  
 
